TechnologyHow Providers Should Use Technology to Meet the EPCS Mandate
Digital health tools that allow providers to electronically prescribe controlled medications can improve care management and curb drug misuse if...
Revenue Cycle5 Demands From the AHA to HHS on Recent 340B Ruling
The district court recently remanded remedy decisions to HHS for its underpayments related to the 340B drug pricing program.
Revenue CycleHow The 340B Payment Drama Defined Revenue Cycle in 2022
The 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and other covered entities at significantly...
Revenue CycleHave a 340B Dispute? Prepare For Possible Changes
HHS released a proposed rule outlining changes it wishes to make to the 340B administrative dispute resolution process.
Revenue Cycle340B Payment Woes Still Abound as Study Points Finger at Drug Companies
A new study says drug companies reduce access to care by limiting 340B community pharmacies.
TechnologyHow Technology Supports Engagement, Adherence in OUD Treatment
In the second of a two-part interview, Brian Clear MD, chief medical officer of Bicycle Health, talks about treatment details...
Supply ChainDrug Supply Chain Security Act 2023 Deadline: 'All Parties Must Do Their Part'
A decade-long process to secure the safety and security of the pharmaceutical supply chain is nearing the finish line.
FinanceResearch Finds Some Hospitals Are Raising The Cost of Cancer Drugs
Forty-four percent of hospitals view the 340B Drug Pricing Program as a critical revenue source.
Clinical CareMedicare Could Save $3.6B on Generic Drugs If Program Could Match Direct-to-Consumer Pricing
Researchers have compared Medicare Part D generic drug pricing with pricing at the Mark Cuban Cost Plus Drug Company.
PayerPharmacy Benefit Managers Backlash: 6 Industry Quotes
Congress, purchasers, and industry analysts weighed in on the role pharmacy benefit managers play in prescription drug costs.
PharmaReuters Pharma Clinical Conference Explores Tech and Patient Trust
Clinical trial innovation must be patient-centered, inclusive, and tech-enabled.
Payer5 Highlights from BlueCare Network's Rx Precision Medicine Pilot
One Michigan plan is bringing predictive power to patient drug treatment.